Isomorphic Labs reported funding talks Ecosystem
Bloomberg reports Isomorphic Labs funding talks at $40 billion-plus value
Developing 1 source
Bloomberg reports that Alphabet's AI drug discovery company Isomorphic Labs is in early fundraising talks at a possible valuation of at least $40 billion.
What happened lately
Bloomberg reported on October 8 that Isomorphic Labs, an Alphabet company spun out of Google DeepMind, is in early talks to raise funding at a valuation of at least $40 billion. One person familiar with the discussions said a round could value the AI drug discovery company as high as $50 billion. Bloomberg said the financing has not closed and its terms could change. The figures are attributed to unnamed people familiar with the matter, not a completed transaction or a valuation announced by Isomorphic Labs.